Quality of life in patients with Fabry disease: a systematic review of the literature
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quality of life in patients with Fabry disease: a systematic review of the literature
Authors
Keywords
Fabry disease, Quality of life, Health related quality of life, Patient reported outcome measures, Enzyme replacement therapy, Systematic review
Journal
Orphanet Journal of Rare Diseases
Volume 10, Issue 1, Pages 77
Publisher
Springer Nature
Online
2015-06-18
DOI
10.1186/s13023-015-0296-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
- (2014) K Wyatt et al. HEALTH TECHNOLOGY ASSESSMENT
- Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis
- (2014) Saskia M. Rombach et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease
- (2014) Martin Wagner et al. BMC Nephrology
- Infusionsbehandlung in häuslicher Umgebung – ein praktikabler Ansatz für chronisch Kranke?
- (2013) M. Beck et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications
- (2013) F. Weidemann et al. JOURNAL OF INTERNAL MEDICINE
- A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
- (2013) L van der Tol et al. JOURNAL OF MEDICAL GENETICS
- A randomised, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of three dosing schedules of agalsidase alfa enzyme replacement therapy for Fabry disease
- (2013) D.A. Hughes et al. MOLECULAR GENETICS AND METABOLISM
- Cost-effectiveness of enzyme replacement therapy for Fabry disease
- (2013) Saskia M Rombach et al. Orphanet Journal of Rare Diseases
- Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
- (2013) Saskia M Rombach et al. Orphanet Journal of Rare Diseases
- P03—Excessive Daytime Sleepiness is a Common Symptom in Fabry Disease
- (2012) T. Duning et al. CLINICAL THERAPEUTICS
- P08—Quality of Life did not Worsen for 7 Years in Enzyme-Replacement Therapy Recipients with Fabry Disease
- (2012) I. Kantola et al. CLINICAL THERAPEUTICS
- Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)
- (2012) Kazuya Tsuboi et al. GENETICS IN MEDICINE
- Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ)
- (2012) Uma Ramaswami et al. Health and Quality of Life Outcomes
- Prevalence of symptoms in female Fabry disease patients: a case-control survey
- (2012) Machtelt G. Bouwman et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Upregulation of inward rectifying currents and Fabry disease neuropathy
- (2012) Nimeshan Geevasinga et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria
- (2012) Thomas P Mechtler et al. LANCET
- Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases
- (2012) Chiara Cazzorla et al. MOLECULAR GENETICS AND METABOLISM
- Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
- (2012) Wills Hughes-Wilson et al. Orphanet Journal of Rare Diseases
- Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS)
- (2011) M.-Á. Barba-Romero et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Impact of growing up with Fabry disease on achievement of psychosocial milestones and quality of life
- (2011) Machtelt G. Bouwman et al. MOLECULAR GENETICS AND METABOLISM
- Response of women with Fabry disease to enzyme replacement therapy: Comparison with men, using data from FOS—the Fabry Outcome Survey
- (2011) Derralynn A. Hughes et al. MOLECULAR GENETICS AND METABOLISM
- Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients
- (2011) Bouwien E Smid et al. Orphanet Journal of Rare Diseases
- Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
- (2011) Carla EM Hollak et al. Orphanet Journal of Rare Diseases
- Neuropsychiatric symptoms and brain structural alterations in Fabry disease
- (2010) I. Schermuly et al. EUROPEAN JOURNAL OF NEUROLOGY
- Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: Findings from the Fabry Registry
- (2010) Torquil Watt et al. GENETICS IN MEDICINE
- Ocular manifestations of Fabry disease within in a single kindred
- (2010) Albert M. Morier et al. OPTOMETRY
- Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data
- (2009) A Mehta et al. LANCET
- Functional and structural nerve fiber findings in heterozygote patients with Fabry disease
- (2009) Anette Torvin Møller et al. PAIN
- Twenty-four-month α-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters
- (2008) J. W. Koskenvuo et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study
- (2008) S Buechner et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry
- (2008) Robert J Hopkin et al. PEDIATRIC RESEARCH
- Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations
- (2007) Robert H. Dworkin et al. JOURNAL OF PAIN
- Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
- (2007) William R. Wilcox et al. MOLECULAR GENETICS AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now